TITLE

Liver Injury during Highly Active Antiretroviral Therapy: The Effect of Hepatitis C Coinfection

AUTHOR(S)
Bonacini, Maurizio
PUB. DATE
March 2004
SOURCE
Clinical Infectious Diseases;3/1/2004 Supplement, Vol. 38, pS104
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Drug-induced liver injury (DILI) is the elevation of liver enzyme and/or bilirubin levels caused by the use of a medication or drug. In patients with human immunodeficiency virus (HIV) infection, some of these events may not be directly caused by medication. Acute viral hepatitis, reactivation of hepatitis B virus or hepatitis C virus (HCV) infection, and/or alcohol use may play roles. Elevated transaminase levels are a signal of liver injury, but most cases improve despite continuation of drug therapy. Approximately 33% of patients with HIV infection are coinfected with HCV. Patients with HIV or HCV infection are more prone to DILI, possibly because of impaired hepatocyte defense mechanisms. HCV coinfection is associated with a 2-10-fold chance of developing elevated transaminase levels during highly active antiretroviral therapy (HAART). Patients with HIV/HCV coinfection should not be denied HAART. Instead, they should be followed-up with monthly liver function tests and referred to specialists if grade 3 or 4 liver enzyme elevations occur.
ACCESSION #
12356596

 

Related Articles

  • Managing Symptomatic Drug-Induced Liver Injury in HIV—Hepatitis C Virus—Coinfected Patients: A Role for Interferon. McGovern, Barbara H.; Birch, Christopher; Zaman, M. Tauheed; Bica, Ioana; Stone, David; Quirk, James R.; Davis, Benjamin; Zachary, Kimon; Basgoz, Nesli; Graeme-Cook, Fiona; Gandhi, Rajesh T. // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, p1386 

    Background. Human immunodeficiency virus (HIV)-infected patients with hepatitis C virus (HCV) coinfection are at increased risk for drug-induced liver injury (DILI) compared with patients with HIV infection alone. The mechanism underlying this observation is unknown. We hypothesized that...

  • Periportal CD4+ Cell Infiltration Increases in HIV/Hepatitis C Virus–Coinfected Patients Commencing ART, Whereas CD8+ Cells Clear From the Liver. Gani, Rino A.; Yunihastuti, Evy; Krisnuhoni, Ening; Saraswati, Henny; Djauzi, Sjamsurizal; Lesmana, Laurentius A.; Lee, Silvia; Price, Patricia // Journal of Infectious Diseases;Aug2014, Vol. 210 Issue 3, p405 

    Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is common in Asia, but the effects of antiretroviral therapy (ART) are unclear. Histopathological changes in the liver are described in a prospective study of HCV-seropositive HIV-infected patients at Cipto...

  • Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus. Berenguer, Juan; von Wichmann, Miguel A.; Quereda, Carmen; Miralles, Pilar; Mallolas, Josép; López-Aldeguer, José; Álvarez-Pellicer, Julio; De Miguel, Julio; Crespo, Manel; Guardiola, Josep M.; Tellez, María J.; Galindo, María J.; Arponen, Sari; Barquilla, Elena; Bellón, José M.; González-García, Juan // Journal of Antimicrobial Chemotherapy (JAC);Dec2011, Vol. 66 Issue 12, p2843 

    Objectives The effects of antiretroviral drugs on the response to pegylated interferon plus ribavirin remain uncertain. We evaluated whether antiretroviral drugs affected the response to pegylated interferon plus ribavirin in patients co-infected with HIV and hepatitis C virus (HCV). Methods We...

  • Can HCV affect the efficacy of anti-HIV treatment? Filippini, P.; Coppola, N.; Scolastico, C.; Liorre, G.; Nocera, R.; Sagnelli, E.; Piccinino, F. // Archives of Virology;May2000, Vol. 145 Issue 5, p937 

    Summary. To evaluate the impact of new antiretroviral combinations (HAART: Highly Active Anti Retroviral Therapy) on HCV replication and liver enzyme levels, we analysed the changes in HCV viremia and aminotransferase levels in HIV and HCV co-infected patients. Moreover, to evaluate the...

  • HIV Infection and Antiretroviral Therapy: Effect on Hepatitis C Virus Quasispecies Variability. Shuhart, Margaret C.; Sullivan, Daniel G.; Bekele, Kirubeal; Harrington, Robert D.; Kitahata, Mari M.; Mathisen, Terri L.; Thomassen, Lisa V.; Emerson, Scott S.; Gretch, David R. // Journal of Infectious Diseases;5/1/2006, Vol. 193 Issue 9, p1211 

    Background. Hepatitis C virus (HCV) quasispecies variability has been associated with liver disease progression. The effects of human immunodeficiency virus (HIV) coinfection and highly active antiretroviral therapy (HAART) on HCV quasispecies variability have not been firmly established....

  • Tests of Liver Injury. Musana, Kenneth A.; Yale, Steven H.; Abdulkarin, Ahmad S. // Clinical Medicine & Research;May2004, Vol. 2 Issue 2, p129 

    Offers information on the diagnosis of liver abnormalities in ambulatory patients. Patterns of liver injury; Evaluation of a patient with mild isolated elevation of alanine transaminase; Description of a serologic method for diagnosing hepatitis C virus.

  • 'Which comes first - the chicken or the egg?': HIV/hepatitis C co-infection and injecting drug users. Poeder, Fiona // HIV Australia;2008, Vol. 8 Issue 1, p30 

    The article examines the association between HIV/hepatitis C co-infection and injecting drug use in Asia. It discusses the disparity between HIV and hepatitis C virus and the issues affecting the ability of individuals co-infected with these viruses to access HIV treatment, including the...

  • Renal transplantation in HIV-infected patients: 2010 update. Trullas, Joan C.; Cofan, Federico; Tuset, Montse; Ricart, María J.; Brunet, Mercedes; Cervera, Carlos; Manzardo, Christian; López-Dieguez, María; Oppenheimer, Federico; Moreno, Asuncion; Campistol, Josep M.; Miro, Jose M. // Kidney International;Apr2011, Vol. 79 Issue 8, p825 

    The prognosis of human immunodeficiency virus (HIV) infection has improved in recent years with the introduction of antiretroviral treatment. While the frequency of AIDS-defining events has decreased as a cause of death, mortality from non-AIDS-related events including end-stage renal diseases...

  • Understanding Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Coinfection. Yee-Joo Tan; Seng Gee Lim; Wanjin Hong // Current HIV Research;Jan2006, Vol. 4 Issue 1, p21 

    In recent years, there has been an alarming increase in the number of cases of coinfection with the human immunodeficiency virus type 1 (HIV-1) and the hepatitis C virus (HCV). It is now known that coinfection of HIV-1 patients by HCV can complicate the treatment of these patients with highly...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics